Researchers discover link between inherited endocrine tumor syndrome and well-studied cell pathway
(Medical Xpress)—A mutation in a protein called menin causes a hereditary cancer syndrome called MEN1 (multiple endocrine neoplasia type 1). Individuals with MEN1 are at a substantially increased risk of ...
Cancer
Apr 24, 2013 |
4 / 5 (1) |
0
|
Research suggests popular diabetes drugs can cause abnormal pancreatic growth in humans
(Medical Xpress)—Individuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine ...
Diabetes
Mar 27, 2013 |
not rated yet |
0
|
Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease?
Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial ...
Cancer
Nov 13, 2012 |
not rated yet |
0
Researchers test new drug for patients with neuroendocrine tumors
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma ...
Cancer
Aug 06, 2012 |
not rated yet |
0
Chemo combo promising for pancreatic neuroendocrine tumors
(HealthDay) -- The combination of temozolomide and bevacizumab seems to benefit patients with advanced pancreatic neuroendocrine tumors (NETs), according to a study published online July 9 in the Journal of ...
Cancer
Jul 13, 2012 |
not rated yet |
0
PET imaging could lead to better care for neuroendocrine cancer
A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear ...
Cancer
Jun 11, 2012 |
not rated yet |
0
Blood test provides 'snapshot' of tumor drug response
(Medical Xpress) -- Counting the number of tumour cells in blood samples taken before and after treatment for advanced neuroendocrine tumors could provide a ‘snapshot’ of how well patients are responding ...
Cancer
Jun 06, 2012 |
not rated yet |
0
|
Researchers validate staging classifications for neuroendocrine pancreatic tumor surgery response
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and ...
Surgery
Apr 03, 2012 |
not rated yet |
0
Everolimus prolongs progression-free survival for patients with neuroendocrine tumors
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of ...
Cancer
Nov 29, 2011 |
not rated yet |
0
|
Researchers discover Achilles' heel in lethal form of prostate cancer
An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted ...
Cancer
Nov 17, 2011 |
5 / 5 (1) |
1
|
Pancreatic cancer 4th most deadly, treatments few
(AP) -- Pancreatic cancer is notoriously lethal - there are almost as many deaths from it each year as there are new cases. The deaths this week of Apple founder Steve Jobs and Nobelist Ralph Steinman bring ...
Cancer
Oct 08, 2011 |
3.8 / 5 (4) |
0
Pancreatic cancer declining, but among most deadly
(AP) -- There are almost as many deaths from it each year as there are new cases. The deaths this week of Apple founder Steve Jobs and Nobelist Ralph Steinman bring unusual attention to this less-well-known ...
Cancer
Oct 06, 2011 |
5 / 5 (1) |
0
Benefits of radionuclide therapy for neuroendocrine tumors
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only i ...
Cancer
Sep 20, 2011 |
5 / 5 (2) |
1
Two genes linked to why telomeres stretch in cancer cells
Scientists at Johns Hopkins have provided more clues to one of the least understood phenomena in some cancers: why the "ends caps" of cellular DNA, called telomeres, lengthen instead of shorten.
Cancer
Jun 30, 2011 |
not rated yet |
0
|
New therapy for childhood neuroblastoma proves feasible and safe
A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emissi ...
Cancer
Jun 29, 2011 |
not rated yet |
1
- Pages: 1
